Nexus Surgical and Medicare Limited
BSE: NEXUSSURGL · Other Financial Services
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nexus Surgical and Medicare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nexus Surgical and Health Care Limited is an Indian company engaged in the trading and distribution of surgical instruments, medical devices, and healthcare equipment. It serves hospitals, clinics, and medical practitioners by providing essential infrastructure and specialized apparatus.
Business Model
The company operates as a distributor within the healthcare supply chain, sourcing medical products to meet the procurement requirements of the domestic Indian market.
Growth Outlook
Growth is driven by the expanding demand for healthcare infrastructure and medical supplies across India. The company continues to explore opportunities within the pharmaceutical supply chain and broader healthcare services.
Key Risks
- Supply Chain Disruptions. Reliance on third-party sourcing makes the company vulnerable to fluctuations in the availability and cost of medical equipment.
- Regulatory Compliance. Changes in Indian healthcare regulations or medical device standards could impact product eligibility and operational costs.
- Market Competition. The medical trading sector is highly fragmented, leading to intense price competition from both established players and new entrants.
- Economic Sensitivity. As a small-cap entity, the company is susceptible to broader economic downturns that may reduce capital expenditure budgets for hospitals and clinics.
Start your research today
Unlock AI insights, financials, peers and live data on Nexus Surgical and Medicare Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹8 Cr
TTM · standalone
NET PROFIT
₹0.73 Cr
TTM · standalone
EPS
₹1.35
TTM · standalone
RETURN ON EQUITY
58.6%
TTM · standalone
P/E
14.0x
Q4 FY26 · standalone
NET PROFIT MARGIN
11.7%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Other Financial Services
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Nexus Surgical and Medicare LimitedNEXUSSURGL | ₹12 Cr | 16.06 | — | 38.0% | 12.2% | 58.6% | — | +20.1% |
Stellant Securities (India) LimitedSTELLANT | ₹597 Cr | 26.16 | — | 909.8% | 18.8% | 243.0% | — | +78.8% |
The Investment Trust Of India LimitedTHEINVEST | ₹496 Cr | 14.89 | — | -22.3% | 20.0% | 5.1% | — | -37.8% |
Regency FincorpREGENCY | ₹407 Cr | 26.44 | — | 72.7% | 69.0% | 10.2% | — | +21.6% |
NDL VenturesNDLVENTURE | ₹403 Cr | 748.13 | — | — | — | 1.3% | — | +32.6% |
Shree Salasar Investment Ltd.SALSAIN | ₹256 Cr | 13.87 | — | 171.2% | 27.0% | 33.2% | — | — |
As of Q4 FY26
Financials
Nexus Surgical and Medicare Limited
BSE: NEXUSSURGL · Other Financial Services
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nexus Surgical and Medicare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nexus Surgical and Health Care Limited is an Indian company engaged in the trading and distribution of surgical instruments, medical devices, and healthcare equipment. It serves hospitals, clinics, and medical practitioners by providing essential infrastructure and specialized apparatus.
Business Model
The company operates as a distributor within the healthcare supply chain, sourcing medical products to meet the procurement requirements of the domestic Indian market.
Growth Outlook
Growth is driven by the expanding demand for healthcare infrastructure and medical supplies across India. The company continues to explore opportunities within the pharmaceutical supply chain and broader healthcare services.
Key Risks
- Supply Chain Disruptions. Reliance on third-party sourcing makes the company vulnerable to fluctuations in the availability and cost of medical equipment.
- Regulatory Compliance. Changes in Indian healthcare regulations or medical device standards could impact product eligibility and operational costs.
- Market Competition. The medical trading sector is highly fragmented, leading to intense price competition from both established players and new entrants.
- Economic Sensitivity. As a small-cap entity, the company is susceptible to broader economic downturns that may reduce capital expenditure budgets for hospitals and clinics.
Start your research today
Unlock AI insights, financials, peers and live data on Nexus Surgical and Medicare Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹8 Cr
TTM · standalone
NET PROFIT
₹0.73 Cr
TTM · standalone
EPS
₹1.35
TTM · standalone
RETURN ON EQUITY
58.6%
TTM · standalone
P/E
14.0x
Q4 FY26 · standalone
NET PROFIT MARGIN
11.7%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Other Financial Services
As of Q4 FY26